Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Biological Psychology|November 16, 1995
P300 from auditory stimuli: intensity and frequency effectsM J Sugg, J PolichHrmagazine : on Human Resource Management|September 6, 1990
New salary system supports changing cultureO Esquibel, J Ning, J SuggJournal of Experimental Psychology. Human Perception and Performance|June 1, 1994
Time course of inhibition in color-response and word-response versions of the Stroop taskM J Sugg, J E McDonaldGastrointestinal Endoscopy|June 7, 2000
Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pyloriL Laine, J Sugg, L Suchower, et al.Diabetes, Obesity & Metabolism|November 6, 2015
Patient-reported outcomes among patients with type 2 diabetes mellitus treated with dapagliflozin in a triple-therapy regimen for 52 weeksS Grandy, C Sternhufvud, A Ryden, et al.Diabetes, Obesity & Metabolism|May 23, 2015
Dapagliflozin-induced weight loss affects 24-week glycated haemoglobin and blood pressure levelsC D Sjöström, M Hashemi, J Sugg, et al.Diabetes, Obesity & Metabolism|July 28, 2015
Durability and tolerability of dapagliflozin over 52 weeks as add-on to metformin and sulphonylurea in type 2 diabetesS Matthaei, K Bowering, K Rohwedder, et al.Diabetes, Obesity & Metabolism|August 6, 2013
Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 yearsJ P H Wilding, V Woo, K Rohwedder, et al.The American Journal of Gastroenterology|January 11, 2001
Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trialsL Laine, M B Fennerty, M Osato, et al.Deutsche Medizinische Wochenschrift (1946)|March 27, 2013
[Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin]J P H Wilding, V Woo, N G Soler, et al.Pageof 2